97 related articles for article (PubMed ID: 21316533)
1. Effectiveness and tolerability of combination treatment of chronic hepatitis C in illicit drug users: meta-analysis of prospective studies.
Zanini B; Covolo L; Donato F; Lanzini A
Clin Ther; 2010 Dec; 32(13):2139-59. PubMed ID: 21316533
[TBL] [Abstract][Full Text] [Related]
2. Treatment for hepatitis C virus and cannabis use in illicit drug user patients: implications and questions.
Fischer B; Reimer J; Firestone M; Kalousek K; Rehm J; Heathcote J
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1039-42. PubMed ID: 16957507
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?
Schaefer M; Heinz A; Backmund M
Addiction; 2004 Sep; 99(9):1167-75. PubMed ID: 15317637
[TBL] [Abstract][Full Text] [Related]
4. Community-based treatment for chronic hepatitis C in drug users: high rates of compliance with therapy despite ongoing drug use.
Wilkinson M; Crawford V; Tippet A; Jolly F; Turton J; Sims E; Hekker M; Dalton J; Marley R; Foster GR
Aliment Pharmacol Ther; 2009 Jan; 29(1):29-37. PubMed ID: 18752631
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic hepatitis C in active drug users.
Davis GL; Rodrigue JR
N Engl J Med; 2001 Jul; 345(3):215-7. PubMed ID: 11463020
[No Abstract] [Full Text] [Related]
6. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
Schaefer M; Schmidt F; Folwaczny C; Lorenz R; Martin G; Schindlbeck N; Heldwein W; Soyka M; Grunze H; Koenig A; Loeschke K
Hepatology; 2003 Feb; 37(2):443-51. PubMed ID: 12540795
[TBL] [Abstract][Full Text] [Related]
7. Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection.
Dore GJ; Thomas DL
Semin Liver Dis; 2005 Feb; 25(1):18-32. PubMed ID: 15731995
[TBL] [Abstract][Full Text] [Related]
8. Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection.
Bini EJ; Bräu N; Currie S; Shen H; Anand BS; Hu KQ; Jeffers L; Ho SB; Johnson D; Schmidt WN; King P; Cheung R; Morgan TR; Awad J; Pedrosa M; Chang KM; Aytaman A; Simon F; Hagedorn C; Moseley R; Ahmad J; Mendenhall C; Waters B; Strader D; Sasaki AW; Rossi S; Wright TL
Am J Gastroenterol; 2005 Aug; 100(8):1772-9. PubMed ID: 16086714
[TBL] [Abstract][Full Text] [Related]
9. Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C.
Manolakopoulos S; Deutsch MJ; Anagnostou O; Karatapanis S; Tiniakou E; Papatheodoridis GV; Georgiou E; Manesis E; Tzourmakliotis D; Archimandritis AJ
Liver Int; 2010 Nov; 30(10):1454-60. PubMed ID: 20846344
[TBL] [Abstract][Full Text] [Related]
10. Treatment of chronic hepatitis C virus infection - Dutch national guidelines.
de Bruijne J; Buster EH; Gelderblom HC; Brouwer JT; de Knegt RJ; van Erpecum KJ; Schalm SW; Bakker CM; Zaaijer HL; Janssen HL; Reesink HW;
Neth J Med; 2008; 66(7):311-22. PubMed ID: 18663263
[TBL] [Abstract][Full Text] [Related]
11. Antiviral treatment for chronic hepatitis C in illicit drug users: a systematic review.
Zanini B; Lanzini A
Antivir Ther; 2009; 14(4):467-79. PubMed ID: 19578232
[TBL] [Abstract][Full Text] [Related]
12. Advances in the treatment of hepatitis C.
Lawrence SP
Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
[TBL] [Abstract][Full Text] [Related]
13. Psychiatric problems in patients infected with hepatitis C before and during antiviral treatment with interferon-alpha: a review.
Quelhas R; Lopes A
J Psychiatr Pract; 2009 Jul; 15(4):262-81. PubMed ID: 19625882
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hepatitis C virus infection in patients with end-stage renal disease.
Liu CH; Kao JH
J Gastroenterol Hepatol; 2011 Feb; 26(2):228-39. PubMed ID: 21261711
[TBL] [Abstract][Full Text] [Related]
15. Treatment for hepatitis C virus infection among current injection drug users in Australia.
Matthews G; Kronborg IJ; Dore GJ
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S325-9. PubMed ID: 15768342
[TBL] [Abstract][Full Text] [Related]
16. [Prevention and treatment of hepatitis C in illicit drug users].
Sakoman S
Acta Med Croatica; 2009 Dec; 63(5):437-42. PubMed ID: 20198904
[TBL] [Abstract][Full Text] [Related]
17. Referral for chronic hepatitis C treatment from a drug dependency treatment setting.
Hallinan R; Byrne A; Agho K; Dore GJ
Drug Alcohol Depend; 2007 Apr; 88(1):49-53. PubMed ID: 17067763
[TBL] [Abstract][Full Text] [Related]
18. [Effectiveness of antiviral therapy in patients with chronic hepatitis C treated by private practice gastroenterologists].
Hofmann WP; Bock H; Weber C; Tacke W; Pfaff R; Kihn R; Moog G; Kellner HU; Schöfer M; Frick B; Berg P; Rambow A; Friedrich-Rust M; Herrmann E; Sarrazin C; Zeuzem S
Z Gastroenterol; 2006 Jan; 44(1):25-31. PubMed ID: 16397836
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy with ribavirin and amantadine in renal transplant patients with chronic hepatitis C virus infection is not superior to ribavirin alone.
Calanca LN; Fehr T; Jochum W; Fischer-Vetter J; Müllhaupt B; Wüthrich RP; Ambühl PM
J Clin Virol; 2007 May; 39(1):54-8. PubMed ID: 17409018
[TBL] [Abstract][Full Text] [Related]
20. Management and therapy of chronic hepatitis C virus infection in HIV-infected individuals.
Mauss S
J HIV Ther; 2007 Mar; 12(1):11-7. PubMed ID: 17589391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]